Loading…
Based on limited metadata, Deb USA Inc. received an FDA Warning Letter on June 11, 2019 regarding drug products. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in the metadata provided. To understand the complete compliance concerns and required corrective actions, the full Warning Letter text would be necessary.